Less Ads, More Data, More Tools Register for FREE

Advanced Oncotherapy appoints COO

Fri, 22nd Nov 2013 07:44
Advanced Oncotherapy has officially appointed Sanjeev Pandya as Chief Operating Officer (COO) and as an Executive Director.Pandya had been acting as COO but has now been taken on permanently for the role with immediate effect. The 45-year-old, who has practised as an orthopaedic surgeon in the NHS in the UK and in developing countries, has previously worked as a strategy consultant with McKinsey & Company and spent two years at Pfizer Global Pharmaceuticals division before joining Lehman Brothers as an investment banker in healthcare mergers and acquisitions. More recently, he has worked as an independent consultant in Russia and at Bupa in London. "Sanjeev's background and commercial experience will add great value to the executive team that he leads as we translate our technology into real world commercial success," said Chairman Lord Evans. RD

Shares in this article

Related News

IN BRIEF: Advanced Oncotherapy financing talks continue, funds delayed
3 May 2024

IN BRIEF: Advanced Oncotherapy financing talks continue, funds delayed

Advanced Oncotherapy PLC - London-based provider of proton therapy for cancer treatment - Provides update in relation to financing discussions and fin...

TRADING UPDATES: Sareum ups retail offer; SThree nabs former ITV exec
2 Apr 2024

TRADING UPDATES: Sareum ups retail offer; SThree nabs former ITV exec

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Sareum + 3 more shares
EARNINGS AND TRADING: Frontier IP sells last of Exscientia holding
29 Feb 2024

EARNINGS AND TRADING: Frontier IP sells last of Exscientia holding

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Frontier Ip + 7 more shares